HK1058665A1 - Optically pure camptothecin analogues. - Google Patents

Optically pure camptothecin analogues.

Info

Publication number
HK1058665A1
HK1058665A1 HK04101371A HK04101371A HK1058665A1 HK 1058665 A1 HK1058665 A1 HK 1058665A1 HK 04101371 A HK04101371 A HK 04101371A HK 04101371 A HK04101371 A HK 04101371A HK 1058665 A1 HK1058665 A1 HK 1058665A1
Authority
HK
Hong Kong
Prior art keywords
optically pure
camptothecin analogues
pure camptothecin
analogues
optically
Prior art date
Application number
HK04101371A
Other languages
English (en)
Inventor
Jean-Bernard Cazaux
Olivier Lavergne
Christine Le Breton
Eric Manginot
Dennis Bigg
Original Assignee
Conseil De Rech S Et D Applica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseil De Rech S Et D Applica filed Critical Conseil De Rech S Et D Applica
Publication of HK1058665A1 publication Critical patent/HK1058665A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04101371A 1997-08-29 2004-02-25 Optically pure camptothecin analogues. HK1058665A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710785A FR2768431B1 (fr) 1997-08-29 1997-08-29 Nouveaux analogues optiquement purs de la camptothecine, nouvel intermediaire de synthese optiquement pur et son procede de preparation

Publications (1)

Publication Number Publication Date
HK1058665A1 true HK1058665A1 (en) 2004-05-28

Family

ID=9510590

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01102373A HK1031732A1 (en) 1997-08-29 2001-04-03 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
HK04101371A HK1058665A1 (en) 1997-08-29 2004-02-25 Optically pure camptothecin analogues.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK01102373A HK1031732A1 (en) 1997-08-29 2001-04-03 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same

Country Status (26)

Country Link
EP (2) EP1007527B1 (xx)
JP (1) JP2001514261A (xx)
KR (1) KR100570254B1 (xx)
CN (3) CN1104434C (xx)
AR (1) AR016856A1 (xx)
AT (1) ATE253069T1 (xx)
AU (1) AU760863B2 (xx)
BR (1) BR9811405A (xx)
CA (1) CA2301739C (xx)
CZ (1) CZ297896B6 (xx)
DE (1) DE69819340T2 (xx)
DK (1) DK1007527T3 (xx)
ES (1) ES2209196T3 (xx)
FR (1) FR2768431B1 (xx)
HK (2) HK1031732A1 (xx)
HR (1) HRP20000110A2 (xx)
HU (1) HUP0003429A3 (xx)
IL (2) IL134437A0 (xx)
NO (1) NO324882B1 (xx)
NZ (1) NZ502862A (xx)
PL (1) PL195289B1 (xx)
PT (1) PT1007527E (xx)
RU (1) RU2233283C2 (xx)
TW (1) TW419479B (xx)
WO (1) WO1999011646A1 (xx)
ZA (1) ZA987445B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790261B1 (fr) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
CN100408582C (zh) * 2004-02-12 2008-08-06 中国人民解放军第二军医大学 高喜树碱类化合物及其制备方法和用途
EP1794127A1 (en) * 2004-09-21 2007-06-13 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Novel processes for the production of useful intermediates
CN100465175C (zh) * 2005-11-29 2009-03-04 中国人民解放军第二军医大学 7-位取代高喜树碱类化合物及作为药物的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
PT835258E (pt) * 1995-06-21 2003-02-28 Sod Conseils Rech Applic Novos analogos de camptotecina, processos para a sua preparacao, sua utilizacao como farmacos e composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
HUP0003429A1 (hu) 2001-07-30
ZA987445B (en) 1999-02-17
HUP0003429A3 (en) 2002-11-28
NZ502862A (en) 2002-10-25
IL134437A0 (en) 2001-04-30
CN1440973A (zh) 2003-09-10
CN1440972A (zh) 2003-09-10
CN1195758C (zh) 2005-04-06
HK1031732A1 (en) 2001-06-22
EP1007527B1 (fr) 2003-10-29
HRP20000110A2 (en) 2001-02-28
NO324882B1 (no) 2007-12-27
EP1378512A1 (fr) 2004-01-07
AU760863B2 (en) 2003-05-22
CZ297896B6 (cs) 2007-04-25
CA2301739C (fr) 2009-11-17
TW419479B (en) 2001-01-21
KR100570254B1 (ko) 2006-04-12
CN1104434C (zh) 2003-04-02
CA2301739A1 (fr) 1999-03-11
FR2768431A1 (fr) 1999-03-19
ATE253069T1 (de) 2003-11-15
EP1007527A1 (fr) 2000-06-14
IL134437A (en) 2006-08-01
KR20010023394A (ko) 2001-03-26
JP2001514261A (ja) 2001-09-11
FR2768431B1 (fr) 2000-03-24
PT1007527E (pt) 2004-03-31
ES2209196T3 (es) 2004-06-16
CN1268948A (zh) 2000-10-04
WO1999011646A1 (fr) 1999-03-11
RU2233283C2 (ru) 2004-07-27
NO20000995L (no) 2000-02-28
NO20000995D0 (no) 2000-02-28
DE69819340T2 (de) 2004-08-19
DE69819340D1 (de) 2003-12-04
PL195289B1 (pl) 2007-08-31
AU8989698A (en) 1999-03-22
DK1007527T3 (da) 2004-03-08
PL338835A1 (en) 2000-11-20
CZ2000711A3 (cs) 2000-08-16
AR016856A1 (es) 2001-08-01
BR9811405A (pt) 2000-08-29

Similar Documents

Publication Publication Date Title
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
HK1025746A1 (en) Syringe.
HK1016976A1 (en) Resorcinyl-triazine.
AU8334298A (en) Nociceptin analogues
GB2309795B (en) Light-emitting module
GB9710562D0 (en) Light delivery
GB9512670D0 (en) Camptothecin analogues
GB9702190D0 (en) Light-emitting module
HK1058665A1 (en) Optically pure camptothecin analogues.
HK1017834A1 (en) Bodyshaper.
ZA200107738B (en) Optically pure camptothecin analogues.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
GB9702599D0 (en) Photodetector
GB9707379D0 (en) Photodetectors
AU5303598A (en) Peg holder
ZA989435B (en) Novel aryloxy-alkyl-dialkylamines.
ZA983698B (en) Estrenes.
ZA98263B (en) O-fucosyltransferase.
ZA986155B (en) (+)-norcisapride.
CA82511S (en) Cannula
GB9720064D0 (en) Easi-2-peg - double peg
GB2329335B (en) Medicament

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110807